Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient characteristic of two groups (case)

From: Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer

  CRT group RT group Statistic value p
Gender    0.056 0.813
Male 24 23
Female 14 15
Age(years)    0.386 0.699
Range 36–70 37–70
Median 59 60.5
KPS score range 60–90 60–90 0.831 0.406
Weight loss    0.482 0.487
≥5% 11 10
<5% 12 13
Histological type    0.502 0.479
Small cell lung cancer 16 13
Non-small cell lung cancer 22 25
Brain metastasis numbers    0.220 0.896
1 12 11
2 ~ 3 7 6
>3 19 21
Diameter of brain metastasis 0.3 ~ 3.8 0.5 ~ 3.5 0.413 0.680
Mean diameter(cm) 1.95 1.94 0.965 0.335
Accompanied with extracranial metastasis 14 16 0.220 0.639
Brain metastasis only 24 22